GD2-CAR PERSIST: Production and Engineering of GD2-Targeted, Receptor Modified T Cells (GD2CART) for Osteosarcoma or Neuroblastoma to Increase Systemic Tumor Exposure
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Margaret Macy
Study ID
Protocol Number: 22-1002
More information available at ClinicalTrials.gov: NCT04539366
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers